Breast reconstruction technology company AirXpanders is almost halfway to a hoped-for $9M funding round.
A new finance chief will take over on Monday at Becton Dickinson & Co. (NYSE:BDX), the company announced this week. BD nabbed Christopher Reidy from his former gig as CFO at ADP Corporation. Reidy has also worked in executive finance roles at NBA Properties Inc. and AT&T.
BD's Suketu Upadhyay, who has worked as CFO since Nov. 2012, will not leave the company, but he will step down a rung to work as senior VP of finance.
"It is a pleasure to welcome Chris to our executive management team," CEO Vincent Forlenza said in prepared remarks. "He possesses significant financial and operational expertise, complemented by strategic and execution skills.
Arch Therapeutics reports more executive shuffling following reverse merger
Arch Therapeutics continued to shuffle its leadership following a reverse merger, announcing a new COO and CFO this week. Both newly minted finance chief Alan Barber and operations chief William Cotter hail from Arch Biosurgery, now a subsidiary following last month's deal.
Here's a look at some of the top funding stories for medical device companies this week.
FDA officials warn against the use of "laparoscopic power morcellation" for the removal of uterine...
Bio-artificial liver maker Vital Therapies takes its IPO even lower, now planning to open at $12 per...
California surgical devices maker Cardica details a public offering of common and preferred stock...